Circumvention of immunity to the adenovirus major coat protein hexon.
about
Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methodsCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsPre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responsesThe influence of innate and pre-existing immunity on adenovirus therapyIdentification of sites in adenovirus hexon for foreign peptide incorporation.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsOvine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivoIdentification of the hexon region of an adenovirus involved in a new outbreak of keratoconjunctivitis.The promise and potential hazards of adenovirus gene therapy.Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responsesConstruction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.Current strategies and future directions for eluding adenoviral vector immunityEncapsulation of recombinant adenovirus into alginate microspheres circumvents vector-specific immune response.Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.Genetic characterisation of adenovirus type 8 isolated in Hiroshima city over a 15 year period.Characterisation of hexon and fibre genes of a novel strain of adenovirus involved in epidemic keratoconjunctivitis.Cell targeting in anti-cancer gene therapyHuman immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.Emerging cancer vaccines: the promise of genetic vectors.Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.Improving adenovirus based gene transfer: strategies to accomplish immune evasion.Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.Pre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Replication-defective vector based on a chimpanzee adenovirus.Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera.Rescue of chimeric adenoviral vectors to expand the serotype repertoire.Structure-based identification of a major neutralizing site in an adenovirus hexon.Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration
P2860
Q24683349-89712672-2182-4BEE-BD01-728B4A4A86BBQ26995655-E299B006-69C5-4F46-939F-475C9BB8D5F5Q27304910-139FF5BA-9984-4D00-B8FD-B73DDE87DDAAQ33655401-2FB38B45-0224-44CF-9953-A0010D3AAEC4Q33737591-671AC7F6-5146-4AEC-8720-A852C6E1BFF1Q33817535-AFF4337D-6E3D-4E11-A8BC-5E1A146D406DQ33817933-2846B7D0-67EE-4B39-9D46-32B9D8829279Q33973214-82E4A72A-45EB-4FDC-BC10-017318274D89Q34219407-20531B84-C7E4-4620-B7F0-9CA6B5174130Q34229968-2F771D7F-9E8E-4A0E-A01E-4C37EE59A774Q34352485-BA75B484-DBED-452F-9B23-459D24E291CDQ34585554-B398946C-2CBA-4DD0-A305-F7E577C4D75FQ34600592-A0F42762-5996-4C63-AE5F-97ED92285CFFQ35186597-7404598E-079D-429A-89D0-546FAA91EA4AQ35586623-98D6E93D-DA7A-4D05-8B45-0584FE310DB4Q35587295-0BE8BA25-3CCA-4159-99E9-30D498BCE046Q36222776-E19127D1-51EA-47C7-B1DE-5A009B8BA173Q36498186-2CF1D738-55C1-405C-BF5D-CA967651C88CQ37123522-815048E0-1D65-4B2D-9AF5-7FC2D61232D6Q37137464-943B8B94-6656-40C9-BD53-B7D0387F95B4Q37191942-6353AF85-EF39-4DD9-AC16-68922F07E305Q37945219-F4012DA8-6640-4518-8B56-353E77CD6542Q38008337-58480342-E466-462B-90AE-4AE439B7E2D8Q38284700-5B2514FC-F385-41D8-BC12-06023E22679FQ38614156-C9AA202A-8102-462D-97CE-340B2839445CQ39605384-2B6D24C4-5366-495F-9058-D29767DA6A49Q39683397-AF7AA26F-4DA6-4BC2-8885-74F3AF7EAEFDQ40188439-3AE46A9A-6BBD-4ECF-92A9-7818004AA684Q42259707-2B671793-45D4-4E47-B2CE-E7DF2F1A3E3EQ58770917-B36F7898-CAD4-4093-B540-9D77D93ECB4F
P2860
Circumvention of immunity to the adenovirus major coat protein hexon.
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Circumvention of immunity to the adenovirus major coat protein hexon.
@ast
Circumvention of immunity to the adenovirus major coat protein hexon.
@en
type
label
Circumvention of immunity to the adenovirus major coat protein hexon.
@ast
Circumvention of immunity to the adenovirus major coat protein hexon.
@en
prefLabel
Circumvention of immunity to the adenovirus major coat protein hexon.
@ast
Circumvention of immunity to the adenovirus major coat protein hexon.
@en
P2093
P2860
P1433
P1476
Circumvention of immunity to the adenovirus major coat protein hexon
@en
P2093
P2860
P304
P577
1998-08-01T00:00:00Z